BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, Laplanche A. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31-37. [PMID: 19047280 DOI: 10.1200/jco.2008.18.0802] [Cited by in Crossref: 348] [Cited by in F6Publishing: 96] [Article Influence: 24.9] [Reference Citation Analysis]
Number Citing Articles
1 Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, Guadagnolo BA. Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Int J Radiat Oncol Biol Phys 2015;93:158-65. [PMID: 26130233 DOI: 10.1016/j.ijrobp.2015.04.047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
2 Ioannidis A, Koutserimpas C, Konstantinidis M, Drikos I, Voulgaris P, Economou N. Dyspnea caused by a giant retroperitoneal liposarcoma: A case report. Oncol Lett 2018;16:1539-42. [PMID: 30008834 DOI: 10.3892/ol.2018.8791] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Bonvalot S, Roland C, Raut C, Le Péchoux C, Tzanis D, Frezza A, Gronchi A. Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.05.010] [Reference Citation Analysis]
4 Messiou C, Morosi C. Imaging in retroperitoneal soft tissue sarcoma. J Surg Oncol 2018;117:25-32. [PMID: 29193092 DOI: 10.1002/jso.24891] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
5 Chen J, Hang Y, Gao Q, Huang X. Surgical Diagnosis and Treatment of Primary Retroperitoneal Liposarcoma. Front Surg 2021;8:672669. [PMID: 34150840 DOI: 10.3389/fsurg.2021.672669] [Reference Citation Analysis]
6 Nishida T, Hølmebakk T, Raut CP, Rutkowski P. Defining Tumor Rupture in Gastrointestinal Stromal Tumor. Ann Surg Oncol 2019;26:1669-75. [PMID: 30868512 DOI: 10.1245/s10434-019-07297-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
7 Cheng W, Qi Y, Wang B, Tian L, Huang W, Chen Y. Characteristics and computed tomography evaluation of primary retroperitoneal tumours: report of 113 cases. Ann R Coll Surg Engl 2017;99:55-9. [PMID: 27513797 DOI: 10.1308/rcsann.2016.0256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP. Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. CA Cancer J Clin. 2018;68:488-505. [PMID: 30328620 DOI: 10.3322/caac.21498] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 17.3] [Reference Citation Analysis]
9 Leiting JL, Bergquist JR, Hernandez MC, Merrell KW, Folpe AL, Robinson SI, Nagorney DM, Truty MJ, Grotz TE. Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size. Sarcoma 2018;2018:7972389. [PMID: 30631245 DOI: 10.1155/2018/7972389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
10 Bill KL, Casadei L, Prudner BC, Iwenofu H, Strohecker AM, Pollock RE. Liposarcoma: molecular targets and therapeutic implications. Cell Mol Life Sci 2016;73:3711-8. [PMID: 27173057 DOI: 10.1007/s00018-016-2266-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
11 Wee-Stekly WW, Mueller MD. Retroperitoneal tumors in the pelvis: a diagnostic challenge in gynecology. Front Surg 2014;1:49. [PMID: 25593973 DOI: 10.3389/fsurg.2014.00049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
12 Roeder F, Ulrich A, Habl G, Uhl M, Saleh-Ebrahimi L, Huber PE, Schulz-Ertner D, Nikoghosyan AV, Alldinger I, Krempien R, Mechtersheimer G, Hensley FW, Debus J, Bischof M. Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis. BMC Cancer 2014;14:617. [PMID: 25163595 DOI: 10.1186/1471-2407-14-617] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
13 Choi AH, Barnholtz-Sloan JS, Kim JA. Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol 2012;23:2449-57. [PMID: 22323436 DOI: 10.1093/annonc/mdr616] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
14 Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos K. Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. J Surg Oncol 2019;120:340-7. [PMID: 31246290 DOI: 10.1002/jso.25606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
15 Crago AM, Dickson MA. Liposarcoma: Multimodality Management and Future Targeted Therapies. Surg Oncol Clin N Am. 2016;25:761-773. [PMID: 27591497 DOI: 10.1016/j.soc.2016.05.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
16 Dziewirski W, Rutkowski P, Nowecki ZI, Morysinski T, Sałamacha M, Kulik A, Kawczynska M, Kasprowicz A, Łyczek J, Ruka W. Surgery combined with brachytherapy in patients with retroperitoneal sarcomas. J Contemp Brachytherapy 2010;2:14-23. [PMID: 28031738 DOI: 10.5114/jcb.2010.13718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
17 Lee PJ, Meshkat B, Sasidharan P, Zahid A, Coker DJ, Solomon MJ. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series. ANZ J Surg 2021. [PMID: 34661958 DOI: 10.1111/ans.17275] [Reference Citation Analysis]
18 Vishnoi JR, Jain A, Misra S, Pareek P, Rao M, Sureka B, Puranik A. Paraneoplastic Syndrome Associated with the Retroperitoneal Dedifferentiated Liposarcoma: an Atypical Presentation and Review of the Literature. Indian J Surg Oncol 2019;10:703-7. [PMID: 31857769 DOI: 10.1007/s13193-019-00971-0] [Reference Citation Analysis]
19 Bianchi A, Pagan-Pomar A, Ramos-Asensio R, Luna-Fra P, Jiménez-Segovia M, Pujol-Cano N, Ochogavia-Seguí A, Martínez-Corcoles JA, González-Argenté FX. Analysis of potential risk factors in the survival of patients with primary retroperitoneal liposarcoma. Cir Esp (Engl Ed) 2021:S0009-739X(21)00253-0. [PMID: 34507818 DOI: 10.1016/j.ciresp.2021.07.009] [Reference Citation Analysis]
20 Trans-Atlantic RPS Working Group. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2016;23:3531-40. [PMID: 27480354 DOI: 10.1245/s10434-016-5336-7] [Cited by in Crossref: 80] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
21 Blay JY, Hindi N, Bollard J, Aguiar S Jr, Angel M, Araya B, Badilla R, Bernabeu D, Campos F, Caro-Sánchez CHS, Carvajal B, Carvajal Montoya A, Casavilca-Zambrano S, Castro-Oliden V, Chacón M, Clara M, Collini P, Correa Genoroso R, Costa FD, Cuellar M, Dei Tos AP, Dominguez Malagon HR, Donati D, Dufresne A, Eriksson M, Farias-Loza M, Fernandez P, Frezza AM, Frisoni T, Garcia-Ortega DY, Gelderblom H, Gouin F, Gómez-Mateo MC, Gronchi A, Haro J, Huanca L, Jimenez N, Karanian M, Kasper B, Lopes David BB, Lopez-Pousa A, Lutter G, Martinez-Said H, Martinez-Tlahuel J, Mello CA, Morales Pérez JM, Moura David S, Nascimento AG, Ortiz-Cruz EJ, Palmerini E, Patel S, Pfluger Y, Provenzano S, Righi A, Rodriguez A, Salas R, Santos TTG, Scotlandi K, Soule T, Stacchiotti S, Valverde C, Waisberg F, Zamora Estrada E, Martin-Broto J. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. Cancer Treat Rev 2022;102:102312. [PMID: 34798363 DOI: 10.1016/j.ctrv.2021.102312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ghadimi M, Bruns CJ. [Systematic surgery of retroperitoneal sarcomas : Imaging-guided planning of surgical strategy]. Chirurg 2019;90:447-56. [PMID: 31001643 DOI: 10.1007/s00104-019-0952-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Barbaro NM. Malignant nerve sheath tumors. J Neurosurg 2013;118:140-1; discussion 141. [PMID: 23101449 DOI: 10.3171/2012.4.JNS11148] [Reference Citation Analysis]
24 Brodowicz T, Amann G, Leithner A, Sztankay A, Kainberger F, Eisterer W, Liegl-Atzwanger B, Rachbauer F, Rath T, Bergmann M, Funovics PT, Ploner F, Windhager R. [Consensus diagnosis and therapy of soft tissue sarcoma]. Wien Klin Wochenschr 2012;124:85-99. [PMID: 22038378 DOI: 10.1007/s00508-011-0079-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Littrup PJ, Bang HJ, Currier BP, Goodrich DJ, Aoun HD, Heilbrun LK, Adam BA. Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol 2013;24:1817-25. [PMID: 24060437 DOI: 10.1016/j.jvir.2013.06.025] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
26 Schimmack S, Büchler MW, Weitz J. [Surgical therapy of abdominal and trunk soft tissue sarcomas]. Chirurg 2009;80:202-8. [PMID: 19221701 DOI: 10.1007/s00104-008-1596-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Tirotta F, Desai A, Ford SJ, Strauss DC, Almond LM. Considerations on "Impact of centralisation of services on outcomes in a rare tumour: Retroperitoneal sarcomas". Eur J Surg Oncol 2020;46:706-7. [PMID: 31668979 DOI: 10.1016/j.ejso.2019.10.025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Ronellenfitsch U, Jakob J. Surgical approaches for retroperitoneal tumors. Surgery in Practice and Science 2021;5:100032. [DOI: 10.1016/j.sipas.2021.100032] [Reference Citation Analysis]
29 Haas R, Stelmes JJ, Zaffaroni F, Sauvé N, Clementel E, Bar-Deroma R, Le Péchoux C, Litière S, Marreaud S, Alyamani N, Andratschke NHJ, Sangalli C, Chung PW, Miah A, Hurkmans C, Gronchi A, Bovée JVMG, Gelderblom H, Kasper B, Weber DC, Bonvalot S. Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092-22092 STRASS trial. Cancer 2022. [PMID: 35536104 DOI: 10.1002/cncr.34239] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Thway K, Jones RL, Noujaim J, Zaidi S, Miah AB, Fisher C. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies. Adv Anat Pathol 2016;23:30-40. [PMID: 26645460 DOI: 10.1097/PAP.0000000000000101] [Cited by in Crossref: 67] [Cited by in F6Publishing: 37] [Article Influence: 11.2] [Reference Citation Analysis]
31 Schmitz R, Adam MA, Blazer DG 3rd. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival. World J Surg Oncol 2019;17:180. [PMID: 31684956 DOI: 10.1186/s12957-019-1728-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Lee JW, Cardona DM, Blazer DG 3rd, Kirsch DG. Response to Central Boost Radiation Therapy in an Unresectable Retroperitoneal Sarcoma: A Case Report. Adv Radiat Oncol 2020;5:1375-9. [PMID: 33305102 DOI: 10.1016/j.adro.2020.05.012] [Reference Citation Analysis]
33 Patkar S, Kattepur AK, Khanna N, Bajpai J. Retroperitoneal Sarcomas: a Current Review on Management. Indian J Surg Oncol. [DOI: 10.1007/s13193-022-01520-y] [Reference Citation Analysis]
34 Xu C, Ma Z, Zhang H, Yu J, Chen S. Giant retroperitoneal liposarcoma with a maximum diameter of 37 cm: a case report and review of literature. Ann Transl Med 2020;8:1248. [PMID: 33178780 DOI: 10.21037/atm-20-1714] [Reference Citation Analysis]
35 Istl AC, Gronchi A. Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas-Looking Forward. Cancers (Basel) 2022;14:1831. [PMID: 35406603 DOI: 10.3390/cancers14071831] [Reference Citation Analysis]
36 Rhu J, Lee KW, Park JB, Kim SJ. Hibernation of masses suspected to be remnant tumors after surgical resection of retroperitoneal liposarcoma is related to improved overall survival. Int J Clin Oncol 2018;23:765-74. [PMID: 29352382 DOI: 10.1007/s10147-018-1243-1] [Reference Citation Analysis]
37 Ricapito NG, Ghobril C, Zhang H, Grinstaff MW, Putnam D. Synthetic Biomaterials from Metabolically Derived Synthons. Chem Rev 2016;116:2664-704. [PMID: 26821863 DOI: 10.1021/acs.chemrev.5b00465] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
38 García-Aceituno L, Villarreal-Garza C, Perfecto M, León-Rodríguez E. Retroperitoneal soft tissue sarcomas: experience at a single institution in Mexico. World J Surg 2010;34:1511-6. [PMID: 20162280 DOI: 10.1007/s00268-010-0473-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Cao S, Li J, Yang K, Zhang J, Xu J, Feng C, Li H. Development and validation of a novel prognostic model for long-term overall survival in liposarcoma patients: a population-based study. J Int Med Res 2020;48:300060520975882. [PMID: 33296604 DOI: 10.1177/0300060520975882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Beckmann MW, Juhasz-Böss I, Denschlag D, Gaß P, Dimpfl T, Harter P, Mallmann P, Renner SP, Rimbach S, Runnebaum I, Untch M, Brucker SY, Wallwiener D. Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG. Geburtshilfe Frauenheilkd 2015;75:148-64. [PMID: 25797958 DOI: 10.1055/s-0035-1545684] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
41 Nathan H, Raut CP, Thornton K, Herman JM, Ahuja N, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 2009;250:970-6. [PMID: 19644351 DOI: 10.1097/SLA.0b013e3181b25183] [Cited by in Crossref: 102] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
42 Park H, Lee S, Kim B, Lim do H, Choi YL, Choi GS, Kim JM, Park JB, Kwon CH, Joh JW. Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control. Medicine (Baltimore). 2016;95:e4435. [PMID: 27512857 DOI: 10.1097/md.0000000000004435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lee SY, Goh BK, Teo MC, Chew MH, Chow PK, Wong WK, Ooi LL, Soo KC. Retroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol. 2011;9:12. [PMID: 21284868 DOI: 10.1186/1477-7819-9-12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
44 Danieli M, Swallow CJ, Gronchi A. How to treat liposarcomas located in retroperitoneum. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.04.020] [Reference Citation Analysis]
45 Tranberg A, Nielsen MK, Sørensen FB, Thygesen K, Verwaal VJ, Sørensen MM, Christensen HK, Funder JA. Intraabdominal and retroperitoneal soft-tissue sarcomas – Surgical treatment and outcomes. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101781] [Reference Citation Analysis]
46 Dorian Yarih GO, Claudia Hs CS, Alethia AC, Mario AB, Emmanuel ME, Ernesto RA. Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas. Rare Tumors 2021;13:2036361320986655. [PMID: 33738084 DOI: 10.1177/2036361320986655] [Reference Citation Analysis]
47 Blair AB, Reames BN, Singh J, Gani F, Overton HN, Beaulieu RJ, Lum YW, Black JH 3rd, Johnston FM, Ahuja N. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution. J Surg Oncol 2018;118:127-37. [PMID: 29878363 DOI: 10.1002/jso.25096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
48 Kirchberg J, Weitz J. [Intra-abdominal and retroperitoneal sarcomas]. Chirurg 2016;87:255-66; quiz 267. [PMID: 26920140 DOI: 10.1007/s00104-016-0156-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Turner BT, Hampton L, Schiller D, Mack LA, Robertson-More C, Li H, Quan ML, Bouchard-Fortier A. Neoadjuvant radiotherapy followed by surgery compared with surgery alone in the treatment of retroperitoneal sarcoma: a population-based comparison. Curr Oncol 2019;26:e766-72. [PMID: 31896947 DOI: 10.3747/co.26.5185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Abdelfatah E, Guzzetta AA, Nagarajan N, Wolfgang CL, Pawlik TM, Choti MA, Schulick R, Montgomery EA, Meyer C, Thornton K, Herman J, Terezakis S, Frassica D, Ahuja N. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features. J Surg Oncol 2016;114:56-64. [PMID: 27076350 DOI: 10.1002/jso.24256] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
51 Zhuang A, Lu W, Fang Y, Ma L, Xu J, Wang J, Tong H, Zhang Y. Prognostic Factors and Nomogram Construction for First Local Recurrent Retroperitoneal Sarcoma Following Surgical Resection: A Single Asian Cohort of 169 Cases. Front Oncol 2022;12:856754. [DOI: 10.3389/fonc.2022.856754] [Reference Citation Analysis]
52 Zhuang A, Wu Q, Tong H, Zhang Y, Lu W. Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma. Cancer Manag Res 2021;13:6633-9. [PMID: 34466033 DOI: 10.2147/CMAR.S321324] [Reference Citation Analysis]
53 Toulmonde M, Bonvalot S, Méeus P, Stoeckle E, Riou O, Isambert N, Bompas E, Jafari M, Delcambre-Lair C, Saada E, Le Cesne A, Le Péchoux C, Blay JY, Piperno-Neumann S, Chevreau C, Bay JO, Brouste V, Terrier P, Ranchère-Vince D, Neuville A, Italiano A; French Sarcoma Group. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol 2014;25:735-42. [PMID: 24567518 DOI: 10.1093/annonc/mdt577] [Cited by in Crossref: 96] [Cited by in F6Publishing: 86] [Article Influence: 12.0] [Reference Citation Analysis]
54 Ichikawa J, Ohba T, Kanda H, Fujita K, Ebata S, Haro H. Spinal Metastasis of Well-Differentiated Liposarcoma Component in Retroperitoneal Dedifferentiated Liposarcoma Treated by Minimally Invasive Surgery. Case Rep Orthop 2018;2018:1708572. [PMID: 30123596 DOI: 10.1155/2018/1708572] [Reference Citation Analysis]
55 Sun W, Zhang H, Zheng B, Zhang R, Wang C, Yan W, Wang B, Qu X, Chen Y. Treatment and prognosis of iliac fossa soft tissue sarcoma: A single-center study. Cancer Commun (Lond) 2020;40:321-6. [PMID: 32459396 DOI: 10.1002/cac2.12028] [Reference Citation Analysis]
56 Nassif NA, Tseng W, Borges C, Chen P, Eisenberg B. Recent advances in the management of liposarcoma. F1000Res 2016;5:2907. [PMID: 28105325 DOI: 10.12688/f1000research.10050.1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
57 Tyler R, Lee M, Ierodiakonou V, Hodson J, Taniere P, Almond M, Ford S, Desai A. Prognostic implications of histological organ involvement in retroperitoneal sarcoma. BJS Open 2021;5:zrab080. [PMID: 34518873 DOI: 10.1093/bjsopen/zrab080] [Reference Citation Analysis]
58 Schwartz PB, Vande Walle K, Winslow ER, Ethun CG, Tran TB, Poultsides G, Tseng J, Roggin K, Grignol V, Howard JH, Krasnick BA, Fields RC, Mogal H, Clarke CN, Senehi R, Votanopoulos K, Cardona K, Abbott DE. Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC). Sarcoma 2019;2019:5395131. [PMID: 31281208 DOI: 10.1155/2019/5395131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
59 Smrke A, Hamm J, Karvat A, Simmons C, Srikanthan A. A retrospective review of 145 patients with angiosarcoma: Radiation therapy, extent of resection and chemotherapy are important predictors of survival. Mol Clin Oncol 2020;13:179-85. [PMID: 32714543 DOI: 10.3892/mco.2020.2055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Aeschbacher P, Kollár A, Candinas D, Beldi G, Lachenmayer A. The Role of Surgical Expertise and Surgical Access in Retroperitoneal Sarcoma Resection – A Retrospective Study. Front Surg 2022;9:883210. [DOI: 10.3389/fsurg.2022.883210] [Reference Citation Analysis]
61 Samà L, Tzanis D, Bouhadiba T, Bonvalot S. Emergency Retroperitoneal Sarcoma Surgery for Preoperative Rupture and Hemoperitoneum: A Case Report. Cureus 2021;13:e13936. [PMID: 33868865 DOI: 10.7759/cureus.13936] [Reference Citation Analysis]
62 Fuu T, Yano A, Urakami S. Undifferentiated pleomorphic sarcoma of the retroperitoneum mimicking a cortisol‐ and catecholamine‐secreting adrenal tumor. IJU Case Reports. [DOI: 10.1002/iju5.12436] [Reference Citation Analysis]
63 Abdelfatah E, Page A, Sacks J, Pierorazio P, Bivalacqua T, Efron J, Terezakis S, Gearhart S, Fang S, Safar B, Pawlik TM, Armour E, Hacker-Prietz A, Herman J, Ahuja N. Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients. J Surg Oncol 2017;115:883-90. [PMID: 28252805 DOI: 10.1002/jso.24597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Pistorius S, Reeps Ch, Weitz J. [Complex pelvic and sarcoma surgery with vascular replacement]. Chirurg 2016;87:108-13. [PMID: 26661949 DOI: 10.1007/s00104-015-0123-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Seidensaal K, Kieser M, Hommertgen A, Jaekel C, Harrabi SB, Herfarth K, Mechtesheimer G, Lehner B, Schneider M, Nienhueser H, Fröhling S, Egerer G, Debus J, Uhl M. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial. Trials 2021;22:134. [PMID: 33579340 DOI: 10.1186/s13063-021-05069-z] [Reference Citation Analysis]
66 Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. The value of surgery for retroperitoneal sarcoma. Sarcoma 2009;2009:605840. [PMID: 19826633 DOI: 10.1155/2009/605840] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
67 Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center. J Surg Oncol. 2018;117:1188-1194. [PMID: 29228466 DOI: 10.1002/jso.24951] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
68 Morizawa Y, Miyake M, Shimada K, Hori S, Tatsumi Y, Nakai Y, Anai S, Tanaka N, Konishi N, Fujimoto K. Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas. World J Surg Oncol 2016;14:43. [PMID: 26911364 DOI: 10.1186/s12957-016-0810-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
69 Lazarides AL, Kerr DL, Nussbaum DP, Kreulen RT, Somarelli JA, Blazer DG 3rd, Brigman BE, Eward WC. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers? Clin Orthop Relat Res 2019;477:718-27. [PMID: 30485258 DOI: 10.1097/01.blo.0000533623.60399.1b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
70 Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 2012;159:14-26. [PMID: 22154931 DOI: 10.1016/j.jconrel.2011.11.031] [Cited by in Crossref: 491] [Cited by in F6Publishing: 440] [Article Influence: 44.6] [Reference Citation Analysis]
71 El-Bared N, Taussky D, Mehiri S, Patocskai E, Roberge D, Donath D. Preoperative intensity modulated radiation therapy for retroperitoneal sarcoma. Technol Cancer Res Treat 2014;13:211-6. [PMID: 23919397 DOI: 10.7785/tcrt.2012.500371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
72 Rhu J, Hyun SH, Lee KH, Jo SJ, Lee KW, Park JB, Kim SJ. Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma. Sci Rep 2019;9:6605. [PMID: 31036901 DOI: 10.1038/s41598-019-43215-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
73 Baldini EH, Bosch W, Kane JM 3rd, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol 2015;22:2846-52. [PMID: 26018727 DOI: 10.1245/s10434-015-4633-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
74 Schmalz O. [Retroperitoneal tumors]. Urologe A 2016;55:748-55. [PMID: 27220892 DOI: 10.1007/s00120-016-0117-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
75 Ye MS, Wu HK, Qin XZ, Luo F, Li Z. Hyper-accuracy three-dimensional reconstruction as a tool for better planning of retroperitoneal liposarcoma resection: A case report. World J Clin Cases 2022; 10(1): 268-274 [DOI: 10.12998/wjcc.v10.i1.268] [Reference Citation Analysis]
76 Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol. 2018;25:2193-2200. [PMID: 29520652 DOI: 10.1245/s10434-018-6417-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
77 Tan MC, Yoon SS. Surgical management of retroperitoneal and pelvic sarcomas. J Surg Oncol 2015;111:553-61. [PMID: 25482329 DOI: 10.1002/jso.23840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
78 Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol 2018;117:1799-805. [PMID: 29723411 DOI: 10.1002/jso.25082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Yoh T, Sata R, Kobayashi A, Wada S, Nakamura Y, Kato T, Nakayama H, Okamura R. A large retroperitoneal malignant solitary fibrous tumor. Int Surg 2014;99:414-8. [PMID: 25058776 DOI: 10.9738/INTSURG-D-13-00087.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
80 Novak M, Perhavec A, Maturen KE, Pavlovic Djokic S, Jereb S, Erzen D. Leiomyosarcoma of the renal vein: analysis of outcome and prognostic factors in the world case series of 67 patients. Radiol Oncol 2017;51:56-64. [PMID: 28265233 DOI: 10.1515/raon-2016-0051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
81 Casadei L, de Faria FCC, Lopez-Aguiar A, Pollock RE, Grignol V. Targetable Pathways in the Treatment of Retroperitoneal Liposarcoma. Cancers (Basel) 2022;14:1362. [PMID: 35326514 DOI: 10.3390/cancers14061362] [Reference Citation Analysis]
82 Sandrucci S, Ponzetti A, Gianotti C, Mussa B, Lista P, Grignani G, Mistrangelo M, Bertetto O, Di Cuonzo D, Ciccone G. Different quality of treatment in retroperitoneal sarcomas (RPS) according to hospital-case volume and surgeon-case volume: a retrospective regional analysis in Italy. Clin Sarcoma Res 2018;8:3. [PMID: 29507712 DOI: 10.1186/s13569-018-0091-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
83 Zheng QG, Sun ZH, Chen JJ, Li JC, Huang XJ. Paratesticular liposarcoma: Two case reports. World J Clin Cases 2021; 9(2): 457-462 [PMID: 33521115 DOI: 10.12998/wjcc.v9.i2.457] [Reference Citation Analysis]
84 Lazar AM. Luteinizing hormone, sex steroids and extracorporeal circulation - a promising link to treat retroperitoneal sarcomas. A reconsideration of cancer treatment. Med Hypotheses 2012;79:474-7. [PMID: 22824092 DOI: 10.1016/j.mehy.2012.06.027] [Reference Citation Analysis]
85 Reynel M, Villegas Y, Werthmann PG, Kiene H, Kienle GS. Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report. Integr Cancer Ther 2021;20:1534735421995258. [PMID: 33618582 DOI: 10.1177/1534735421995258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Garcia-ortega DY, Ponce-herrera D, Alvarez-cano A, Caro-sanchez C, Luna-ortiz K. Preoperative Neutrophil to Lymphocyte Ratio (NLR), Lymphocyte to Monocyte Ratio (LMR), and Platelet to Lymphocyte Ratio (PLR) as Prognostic Markers in Patients With Retroperitoneal Liposarcoma. Surgery in Practice and Science 2022. [DOI: 10.1016/j.sipas.2022.100076] [Reference Citation Analysis]
87 Xie F, Qin D, Lian L, Li M, Kong X, Xia X, Yu C, Luo C, Li W. Establishment of an orthotopic perirenal space xenograft mouse model of retroperitoneal sarcoma. Cancer Commun (Lond) 2021;41:631-4. [PMID: 33984192 DOI: 10.1002/cac2.12162] [Reference Citation Analysis]
88 Avancès C, Rigaud J, Camparo P, Durand X, Sèbe P, Fléchon A, Murez T, Coloby P, Soulié M; Les membres du CCAFU. [CCAFU's contribution to the French National Cancer Institute's reference frame: Retroperitoneal sarcomas]. Prog Urol 2013;23 Suppl 2:S161-6. [PMID: 24485290 DOI: 10.1016/S1166-7087(13)70053-8] [Reference Citation Analysis]
89 Novak M, Perhavec A, Kerin Povšič M, Arnuš M, Eržen D. Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center. World J Surg Oncol 2020;18:277. [PMID: 33109203 DOI: 10.1186/s12957-020-02038-9] [Reference Citation Analysis]
90 Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol 2011;9:143. [PMID: 22054416 DOI: 10.1186/1477-7819-9-143] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
91 Rhu J, Cho CW, Lee KW, Park H, Park JB, Choi YL, Kim SJ. Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening. Medicine (Baltimore) 2017;96:e7537. [PMID: 28816941 DOI: 10.1097/MD.0000000000007537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
92 Kwong ML, Lee B, Kunihira K, Sutjiadi B, Reeves ME, Selleck M, Yang G, Solomon N. Treatment Factors Associated With Overall Survival in Retroperitoneal Sarcoma: An Institutional Review. Am Surg 2020;86:1358-62. [PMID: 33124890 DOI: 10.1177/0003134820964460] [Reference Citation Analysis]
93 Willis F, Schneider M. [Retroperitoneal soft tissue sarcoma: surgical management]. Chirurg 2021. [PMID: 34596706 DOI: 10.1007/s00104-021-01506-6] [Reference Citation Analysis]
94 Avancès C, Camparo P, Quenet F, Durand X, Culine S, Sèbe P, Soulié M, Rigaud J; Comité de Cancérologie de l'Association Française d'Urologie - groupe Organes Génitaux Externes (CCAFU-OGE). [Natural history and management of retroperitoneal sarcoma: Review of the literature by the Oncology committee of the French association of urology]. Prog Urol 2011;21:441-7. [PMID: 21693353 DOI: 10.1016/j.purol.2010.09.029] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Abarca T, Gao Y, Monga V, Tanas MR, Milhem MM, Miller BJ. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol 2018;117:1479-86. [PMID: 29633281 DOI: 10.1002/jso.25052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
96 Trovik LH, Ovrebo K, Almquist M, Haugland HK, Rissler P, Eide J, Engellau J, Monge OR, Nyhus AB, Elde IK, Jebsen NL. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients. Acta Oncol 2014;53:1165-72. [PMID: 25000415 DOI: 10.3109/0284186X.2014.921723] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
97 Hager S, Makowiec F, Henne K, Hopt UT, Wittel UA. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma. Radiat Oncol 2017;12:29. [PMID: 28126006 DOI: 10.1186/s13014-017-0769-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
98 Rhu J, Cho CW, Lee KW, Park JB, Kim SJ. Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study. Int J Clin Oncol 2019;24:583-9. [PMID: 30604162 DOI: 10.1007/s10147-018-01383-w] [Reference Citation Analysis]
99 Salerno KE. Radiation Therapy for Soft Tissue Sarcoma. Surgical Clinics of North America 2022. [DOI: 10.1016/j.suc.2022.04.001] [Reference Citation Analysis]
100 Wasif N. Comparative effectiveness research for sarcoma. Cancer Treat Res 2015;164:51-65. [PMID: 25677018 DOI: 10.1007/978-3-319-12553-4_4] [Reference Citation Analysis]
101 Avancès C, Rigaud J, Bui B, Camparo P, Culine S, Durand X, Sèbe P, Soulié M. Sarcomes du rétropéritoine : Contribution du CCAFU au référentiel INCa. Progrès en Urologie 2010;20:S290-6. [DOI: 10.1016/s1166-7087(10)70045-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Yan Y, Xia S, Teng D, Hu S, Li S, Wang Y, Du X, Li R. Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients. Ann Transl Med 2020;8:1450. [PMID: 33313195 DOI: 10.21037/atm-20-6316] [Reference Citation Analysis]
103 Takatsu F, Yamamoto H, Tomioka Y, Tanaka S, Shien K, Suzawa K, Miyoshi K, Otani S, Okazaki M, Sugimoto S, Yamane M, Takahashi K, Toyooka S. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. World J Surg Oncol 2022;20:114. [PMID: 35395855 DOI: 10.1186/s12957-022-02552-y] [Reference Citation Analysis]
104 Wang Z, Wu JH, Lv A, Li CP, Tian XY, Hao CY. Anterior Approach to En Bloc Resection in Left-Sided Retroperitoneal Sarcoma with Adjacent Organ Involvement: A Study of 25 Patients in a Single Center. Med Sci Monit 2018;24:961-9. [PMID: 29449525 DOI: 10.12659/msm.908559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
105 Albertsmeier M, Werner J, Lindner LH, Belka C, Issels RD, Angele MK. [Operative therapy of abdominal and retroperitoneal sarcoma]. Chirurg 2014;85:391-7. [PMID: 24736805 DOI: 10.1007/s00104-013-2688-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
106 Ren H, Bazhin AV, Pretzsch E, Jacob S, Yu H, Zhu J, Albertsmeier M, Lindner LH, Knösel T, Werner J, Angele MK, Bösch F. A novel immune-related gene signature predicting survival in sarcoma patients. Mol Ther Oncolytics 2022;24:114-26. [PMID: 35024438 DOI: 10.1016/j.omto.2021.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 DeLaney TF, Chen YL, Baldini EH, Wang D, Adams J, Hickey SB, Yeap BY, Hahn SM, De Amorim Bernstein K, Nielsen GP, Choy E, Mullen JT, Yoon SS. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol 2017;2:85-93. [PMID: 28740917 DOI: 10.1016/j.adro.2016.12.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
108 Yang B, Guo WH, Lan T, Yuan F, Liu GJ, Zan RY, You X, Tan QY, Liao ZY. CT-guided 125I seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy. Exp Ther Med. 2016;12:3843-3850. [PMID: 28101168 DOI: 10.3892/etm.2016.3897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
109 Chen Y, Hao J, Yang Y, Yang J, Hao X. Tumor rupture predicts early metastasis and poor prognosis in stage III soft tissue sarcomas. World J Surg 2011;35:1002-9. [PMID: 21331475 DOI: 10.1007/s00268-011-0995-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
110 Schmitz E, Nessim C. Retroperitoneal Sarcoma Care in 2021. Cancers (Basel) 2022;14:1293. [PMID: 35267600 DOI: 10.3390/cancers14051293] [Reference Citation Analysis]
111 Mohindra P, Neuman HB, Kozak KR. The role of radiation in retroperitoneal sarcomas. Curr Treat Options Oncol 2013;14:425-41. [PMID: 23649911 DOI: 10.1007/s11864-013-0236-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
112 Angele MK, Albertsmeier M, Prix NJ, Hohenberger P, Abdel-Rahman S, Dieterle N, Schmidt M, Mansmann U, Bruns CJ, Issels RD, Jauch KW, Lindner LH. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 2014;260:749-54; discussion 754-6. [PMID: 25379845 DOI: 10.1097/SLA.0000000000000978] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 6.1] [Reference Citation Analysis]
113 Fan W, Niu L, Wang Y, Zhang Y, Yao X, Tan G, Yang J, Li J. Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efficacy. Oncotarget 2016;7:42639-49. [PMID: 27223071 DOI: 10.18632/oncotarget.9476] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
114 Volkov AY, Nered SN, Kozlov NA, Stilidi IS, Archery PP, Antonova EY, Privezentsev SA. [Active surgical approach for retroperitoneal liposarcoma]. Khirurgiia (Mosk) 2021;:5-11. [PMID: 34786910 DOI: 10.17116/hirurgia20211115] [Reference Citation Analysis]
115 Pastorino U, Scanagatta P, Girotti P, Rolli L, Gronchi A. Long-Term Results of Thoraco-Pleuro-Pneumonectomy (TPP) for Recurrent Thoracic Sarcomas. Ann Surg Oncol 2017;24:551-4. [PMID: 29159736 DOI: 10.1245/s10434-017-6219-2] [Reference Citation Analysis]
116 Siew CC, Cardona K, van Houdt WJ. Management of recurrent retroperitoneal sarcomas. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.06.008] [Reference Citation Analysis]
117 Uehara F, Hiroshima Y, Miwa S, Tome Y, Yano S, Yamamoto M, Matsumoto Y, Maehara H, Tanaka K, Bouvet M, Kanaya F, Hoffman RM. Fluorescence-guided surgery of retroperitoneal-implanted human fibrosarcoma in nude mice delays or eliminates tumor recurrence and increases survival compared to bright-light surgery. PLoS One 2015;10:e0116865. [PMID: 25710463 DOI: 10.1371/journal.pone.0116865] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
118 Zaenkert EK, Bruns CJ, Winter H, Rentsch M, Jauch KW, Hardin G, Angele MK. Resection of sarcoma involving the intrahepatic vena cava: report of 2 cases from a specialized center. Ann Vasc Surg 2013;27:498.e9-13. [PMID: 23541777 DOI: 10.1016/j.avsg.2012.06.018] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
119 Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, Moraco N, Crago AM, Singer S. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Ann Surg 2016;263:593-600. [PMID: 25915910 DOI: 10.1097/SLA.0000000000001149] [Cited by in Crossref: 124] [Cited by in F6Publishing: 32] [Article Influence: 20.7] [Reference Citation Analysis]
120 Luo P, Cai W, Yang L, Chen S, Wu Z, Chen Y, Zhang R, Shi Y, Yan W, Wang C. Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection. Cancer Manag Res 2018;10:4727-34. [PMID: 30425569 DOI: 10.2147/CMAR.S171602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
121 Montero A, Nuñez M, Hernando O, Vicente E, Ciervide R, Zucca D, Sanchez E, López M, Quijano Y, Garcia-Aranda M, Alonso R, Valero J, Chen X, Alvarez B, Fernandez-Leton P, Rubio C. Retroperitoneal soft-tissue sarcomas: Radiotherapy experience from a tertiary cancer center and review of current evidence. Rep Pract Oncol Radiother 2020;25:643-55. [PMID: 32565743 DOI: 10.1016/j.rpor.2020.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter? Am J Clin Oncol 2019;42:160-5. [PMID: 30394881 DOI: 10.1097/COC.0000000000000486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
123 Siew CCH, Apte SS, Baia M, Gyorki DE, Ford S, van Houdt WJ. Retroperitoneal and Mesenteric Liposarcomas. Surg Oncol Clin N Am 2022;31:399-417. [PMID: 35715141 DOI: 10.1016/j.soc.2022.03.005] [Reference Citation Analysis]
124 Villano AM, Vidri RJ, Vo ET, Greco SH, Howell KJ, von Mehren M, Farma JM. National Trends in Treatment for Retroperitoneal Soft Tissue Sarcoma: A Modern Appraisal of Variability in Therapeutic Strategies. Ann Surg Oncol 2021. [PMID: 34635978 DOI: 10.1245/s10434-021-10908-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Sargos P, Dejean C, de Figueiredo BH, Brouste V, Nguyen Bui B, Italiano A, Stoeckle E, Kantor G. High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma. Radiat Oncol 2012;7:214. [PMID: 23245199 DOI: 10.1186/1748-717X-7-214] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
126 Mastoraki A, Schizas D, Papanikolaou IS, Bagias G, Machairas N, Agrogiannis G, Liakakos T, Arkadopoulos N. Management of primary retroperitoneal synovial sarcoma: A case report and review of literature. World J Gastrointest Surg 2019; 11(1): 27-33 [PMID: 30705737 DOI: 10.4240/wjgs.v11.i1.27] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Strauss DC, Hayes AJ, Thomas JM. Retroperitoneal tumours: review of management. Ann R Coll Surg Engl 2011;93:275-80. [PMID: 21944791 DOI: 10.1308/003588411X571944] [Cited by in Crossref: 78] [Cited by in F6Publishing: 28] [Article Influence: 7.1] [Reference Citation Analysis]
128 Mansfield SA, Pollock RE, Grignol VP. Surgery for Abdominal Well-Differentiated Liposarcoma. Curr Treat Options Oncol 2018;19:1. [PMID: 29335908 DOI: 10.1007/s11864-018-0520-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
129 Wang S, Han X, Liu S, Xu G, Li J. Primary retroperitoneal liposarcoma: a rare case report. J Int Med Res 2021;49:3000605211063085. [PMID: 34878928 DOI: 10.1177/03000605211063085] [Reference Citation Analysis]
130 Cananzi FCM, Ruspi L, Samà L, Sicoli F, Gentile D, Minerva EM, Cozzaglio L, Quagliuolo V. Short-term outcomes after duodenal surgery for mesenchymal tumors: a retrospective analysis from a single tertiary referral center. Updates Surg 2019;71:451-6. [PMID: 31270684 DOI: 10.1007/s13304-019-00667-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
131 Kammar P, Gheewala HM, Raju BN, Behranwala AA, Anam JR, Mehta S. Aortic Resection with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Case Report. Indian J Surg Oncol 2020;11:121-4. [PMID: 33088146 DOI: 10.1007/s13193-020-01089-4] [Reference Citation Analysis]
132 Lee HS, Yu JI, Lim DH, Kim SJ. Retroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic factors. Radiat Oncol J. 2016;34:216-222. [PMID: 27730802 DOI: 10.3857/roj.2016.01858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
133 Matthyssens LE, Creytens D, Ceelen WP. Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg 2015;2:4. [PMID: 25713799 DOI: 10.3389/fsurg.2015.00004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
134 Sargos P, Stoeckle E, Henriques de Figueiredo B, Antoine M, Delannes M, Mervoyer A, Kantor G. [Radiotherapy for retroperitoneal sarcomas]. Cancer Radiother 2016;20:677-84. [PMID: 27568294 DOI: 10.1016/j.canrad.2016.07.040] [Reference Citation Analysis]
135 Lou J, Moten AS, Reddy SS, Howell KJ, Movva S, von Mehren M, Farma JM. Retroperitoneal Sarcomas: Does Laterality Matter? J Surg Res 2019;244:34-41. [PMID: 31279261 DOI: 10.1016/j.jss.2019.05.016] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
136 Ikoma N, Torres KE, Somaiah N, Hunt KK, Cormier JN, Tseng W, Lev D, Pollock R, Wang WL, Feig B. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol 2015;22:1068-72. [PMID: 25354575 DOI: 10.1245/s10434-014-4210-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
137 Brodbeck R, Horch RE, Arkudas A, Beier JP. Plastic and Reconstructive Surgery in the Treatment of Oncological Perineal and Genital Defects. Front Oncol 2015;5:212. [PMID: 26500887 DOI: 10.3389/fonc.2015.00212] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
138 Yoon SS, Chen YL, Kirsch DG, Maduekwe UN, Rosenberg AE, Nielsen GP, Sahani DV, Choy E, Harmon DC, DeLaney TF. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol 2010;17:1515-29. [PMID: 20151216 DOI: 10.1245/s10434-010-0935-1] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 6.0] [Reference Citation Analysis]
139 Xiao J, Liu J, Chen M, Liu W, He X. Diagnosis and Prognosis of Retroperitoneal Liposarcoma: A Single Asian Center Cohort of 57 Cases. J Oncol 2021;2021:7594027. [PMID: 34035812 DOI: 10.1155/2021/7594027] [Reference Citation Analysis]
140 Rhu J, Cho CW, Lee KW, Park H, Park JB, Choi YL, Kim SJ. Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival. World J Surg 2018;42:254-62. [PMID: 28808758 DOI: 10.1007/s00268-017-4157-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]